Degenerative Disc Disease - Pipeline Insights, 2017

  • ID: 4330961
  • Drug Pipelines
  • Region: Global
  • 76 pages
  • DelveInsight
UP TO OFF
until Dec 31st 2018
1 of 4

FEATURED COMPANIES

  • AnGes
  • BiologicsMD
  • Biopharm
  • BioRestorative Therapies
  • Bone Therapeutics
  • DiscGenics
  • MORE
Degenerative Disc Disease - Pipeline Insights, 2017 provides comprehensive insights about pipeline drugs across this indication. This report further provides information on the therapeutic development of more than 10+ pipeline drugs at various stages covering Phase II, Phase I, Pre-clinical and Discovery therapeutics and contains a comparative assessment by monotherapy, route of administration and molecule type. The report further features the dormant products for this indication. Leading companies in this space are Bone Therapeutics, Yuhan Corporation, BioRestorative Therapies and AnGes,.

Comparative analysis of pipeline drugs at various stages and their therapeutic assessment by product type and molecule type provides additional and vital details of the pipeline drugs. Information on various technologies involved in the development of pipeline therapeutics along with all the collaborations and agreements of the respective company brings added the advantage of this report. Patent and Financing details related to the products are also provided.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AnGes
  • BiologicsMD
  • Biopharm
  • BioRestorative Therapies
  • Bone Therapeutics
  • DiscGenics
  • MORE
Overview
Causes
Pathophysiology
Symptoms
Diagnosis
Treatment
Conservative Treatment for DDD
Surgical treatment for DDD
Alternative treatment for DDD
Pipeline Therapeutics (Active Products)
Comparative Analysis
Mid Stage Products (Phase II)
Comparative Analysis
ALLOB: Bone Therapeutics
Product Description
Research and Development
Product Development Activities
More drugs in detailed report
Early Stage Products (Phase I)
Comparative Analysis
AMG-0101: AnGes
Product Description
Research and Development
Product Development Activities
More drugs in detailed report
Pre-clinical and Disciovery Stage Products
Comparative Analysis
AMG-0103: AnGes
Product Description
Research and Development
Product Development Activities
More drugs in detailed report
Therapeutic Assessment: Active Products
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type
Other Drugs
Teriparatide: Eli Lilly
Product Description
Research and Development
Product Development Activities
Teriparatide: Asahi Kasei Pharma
Product Description
Research and Development
Dormant Products
Appendix

List of Tables
Table 1: Total Products for Degenerative Disc Disease
Table 2: Mid Stage Products (Phase II)
Table 3: Early Stage Products (Phase I)
Table 4: Pre-clinical Stage Products
Table 5: Discovery Stage Products
Table 6: Assessment by Monotherapy Products
Table 7: Assessment by Combination Products
Table 8: Assessment by Route of Administration
Table 9: Assessment by Stage and Route of Administration
Table 10: Assessment by Molecule Type
Table 11: Assessment by Stage and Molecule Type
Table 12: List of Dormant Products

List of Figures
Figure 1: Principal Cell Death Pathway involved in Intervertebral Disc Degeneration
Figure 2: Symptoms of Degenerative Disc Disease
Figure 3: Total Products for Degenerative Disc Disease
Figure 4: Mid Stage Products (Phase II)
Figure 5: Early Stage Products (Phase I)
Figure 6: Pre-clinical Stage Products
Figure 7: Discovery Stage Products
Figure 8: Assessment by Monotherapy Products
Figure 9: Assessment by Combination Products
Figure 10: Assessment by Route of Administration
Figure 11: Assessment by Stage and Route of Administration
Figure 12: Assessment by Molecule Type
Figure 13: Assessment by Stage and Molecule Type
Figure 14: Dormant Products
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bone Therapeutics
  • BioRestorative Therapies
  • TETEC
  • Yuhan Corporation
  • AnGes
  • BiologicsMD
  • DiscGenics
  • Biopharm
  • TissueGene
  • others
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll